NSE · JBCHEPHARM
J B Chemicals & Pharmaceuticals Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹836 Cr with net profit ₹97 Cr — a 11.54% net margin, versus 16.86% the period before.
Shareholding
As of 2026-03-31
- Promoter48.8%
- Public13.48%
- FII16.33%
- DII21.38%
74,043 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.54× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Pharmaceuticals - Indian - Bulk Drugs & Formln · ranked #14 of 102 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | ₹4,77,444 Cr | 176.1 | 5.71 | 13.74% | 19.72% |
| Cipla Ltd. | ₹1,19,101 Cr | 214.6 | 3.46 | 11.27% | 14% |
| Zydus Lifesciences Ltd. | ₹1,11,990 Cr | 88.75 | 4.13 | 18.59% | 18.86% |
| Lupin Limited | ₹1,11,885 Cr | 19.67 | 4.98 | 23.76% | 19.4% |
| Mankind Pharma Limited | ₹1,07,077 Cr | 192.91 | 6.57 | 11.74% | 13.4% |
| Laurus Labs Limited | ₹96,246 Cr | 88.01 | 18.16 | 16.77% | 15.04% |
| Dr Reddys Laboratories Ltd. | ₹95,344 Cr | 431.06 | 2.52 | 0.11% | 0.12% |
| Aurobindo Pharma Ltd. | ₹92,388 Cr | 100.3 | 2.44 | 9.25% | 10.5% |
| Biocon Ltd. | ₹69,837 Cr | 545.38 | 2.05 | 1.14% | 2.3% |
| Alkem Laboratories Ltd. | ₹67,823 Cr | 286.92 | 4.91 | 16.66% | 15.65% |
| J B Chemicals & Pharmaceuticals Ltd.(this company) | ₹38,677 Cr | 379.35 | 9.3 | 17.06% | 17.1% |
AI analysis
AI-generated · google/gemini-2.5-flashJ B Chemicals & Pharmaceuticals Ltd. is listed on the Indian markets with a market capitalization of Rs 38677 Cr. The company reported revenue of Rs 4207.94 Cr and a Net Profit of Rs 709.47 Cr for the period ending March 2026. Earnings per share (EPS) for the same period stood at Rs 44.19.
Positives
- +The company has a debt-to-equity ratio of 0, indicating zero debt.
- +Return on Capital Employed (ROCE) is 22.99%, and Return on Equity (ROE) is 18.7%.
- +Promoter holding of 48.80% as of March 31, 2026, shows significant insider investment.
- +No shares are pledged by promoters.
Negatives
- −Revenue growth data is not available.
- −Profit margin data is not available.
- −Historical shareholding data for FII, DII, public and promoter for most periods before November 2018 is not available.
- −Dividend yield information is not available.
Financial Performance
For the financial year ending March 2026, J B Chemicals & Pharmaceuticals Ltd. recorded a revenue of Rs 4207.94 Cr. The company's net profit for this period was Rs 709.47 Cr, with earnings per share (EPS) at Rs 44.19. EBITDA for March 2026 was Rs 985.08 Cr.
Profitability & Returns
J B Chemicals & Pharmaceuticals Ltd. achieved a Return on Equity (ROE) of 18.7% and a Return on Capital Employed (ROCE) of 22.99%. The company's earnings per share (EPS) were Rs 44.19. The Price to Earnings ratio (PE) is 46.69, and the book value per share is Rs 259.05.
Balance Sheet
The company maintains a low debt-to-equity ratio of 0, indicating no debt. The book value per share is Rs 259.05. No figures are available for other balance sheet metrics.
Ownership & Pledges
As of March 31, 2026, promoter holding in J B Chemicals & Pharmaceuticals Ltd. was 48.80%. Foreign Institutional Investors (FIIs) held 16.33% and Domestic Institutional Investors (DIIs) held 21.38%. Public shareholding was 13.48%, with institutions holding 37.72%. There are no pledged promoter shares.
Quarterly Performance
In the quarter ending March 2026, revenue was Rs 904.23 Cr, with a net profit of Rs 101.37 Cr and EBITDA of Rs 163.1 Cr. This follows a revenue of Rs 1064.72 Cr and a net profit of Rs 197.89 Cr in December 2025.
Data as of — price: 2026-07-30 · financials: Mar 26 · shareholding: Mar 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to J B Chemicals & Pharmaceuticals Ltd.share price & fundamentals